Zacks Recent Price Strength Strategy Highlights: Bio-Imaging Technologies, Cholestech Corp., Gardner Denver and New Frontier Media.
Here are details about four companies currently identified by the Recent Price Strength Profit Track:
Bio-Imaging Technologies, Inc. (Nasdaq: BITI), a Zacks #1 Rank (Strong Buy) company, has been setting new 52-week highs. In early November, the company reported third-quarter earnings of three cents per share, reversing last year's loss of five cents and exceeding the consensus estimate by two cents. Bio-Imaging Technologies mentioned that it has improved its profitability in the third quarter while continuing to grow its backlog. BITI experienced 22% growth over the past four weeks.
Cholestech Corp. (Nasdaq: CTEC) posted fiscal second-quarter earnings of 15 cents per share late October. The result beat the previous year's 11 cents and eclipsed the consensus estimate almost 37%. The company said this past quarter and the first half of fiscal 2007, Cholestech has demonstrated significant operating leverage in addition to double digit revenue growth. This fact is reflected in the company's improved operating margin and continued strong cash flow. CTEC is within reach of its 52-week high and experienced 3% growth over the past four weeks.
Gardner Denver, Inc. (NYSE: GDI) announced third-quarter earnings of 60 cents per share in late October, nearly doubling the year-ago result and surpassing the consensus estimate by 9%. The company noted that its results reflect continued strength in its end market segments and its outlook remains positive. GDI has advanced in share price by 2% over the past four weeks and currently trades near its 52-week high.
New Frontier Media, Inc. (Nasdaq: NOOF) is close to its 52-week high. NOOF's share price increased by 5% over the past four weeks. In early November, the company released fiscal second-quarter earnings of 15 cents per share, outperforming the previous year's 11 cents and jumping ahead of the consensus estimate by 25%. Revenue increased 43% on a year-over-year basis.
Discover all the current stocks currently on the Recent Price Strength Profit Track at: http://at.zacks.com/?id=1864
About Profit Tracks
What is a "Profit Track"? Each Profit Track is a successful stock picking strategy with proven results through the Bear Market of 2001-2002 and the Bull run started in 2003. On Zacks.com we have created these nine unique screens to offer investors great strategies to potentially outperform the market in the years ahead. For the first five months of 2006, the Low Price Stocks strategy was the top performing Profit Track with a return of +22.2% followed by the Discounted Fundamental screen with a +18.6% return. To see all nine strategies along with philosophy, past performance and current stocks, go to http://at.zacks.com/?id=1838
All the Profit Track strategies were created and backtested using the Research Wizard software from Zacks Investment Research. If you like this screening strategy, but want to narrow down the list of stocks and even improve the performance, then you should start a free trial to this powerful stock picking tool. Learn more about the Research Wizard free trial offer and our new special report "Top 10 Stock Screening Strategies" at http://at.zacks.com/?id=2156
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind Zacks is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. The goal is to unlock these pros' profitable insights for individual investors hard-pressed to find this valuable information in one source. A free subscription to "Profit from the Pros" weekly e-mail newsletter provides the best way to use these experts' insights for more profitable investing. Register for a free subscription to the Profit from the Pros newsletter at http://at.zacks.com/?id=1841
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
(a)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard and Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 21, 2006|
|Previous Article:||NHC and NHR Announce Proposed Merger.|
|Next Article:||Nelson Chan Named Chief Executive Officer of Magellan.|